ssarx subspace identification algorithm Search Results


ez-link alkoxyamine-peg4-ss-biotin (ssarp  (Thermo Fisher)
90
Thermo Fisher ez-link alkoxyamine-peg4-ss-biotin (ssarp
Ez Link Alkoxyamine Peg4 Ss Biotin (Ssarp, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ez-link alkoxyamine-peg4-ss-biotin (ssarp/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
ez-link alkoxyamine-peg4-ss-biotin (ssarp - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ssarx subspace identification algorithm  (MathWorks Inc)
90
MathWorks Inc ssarx subspace identification algorithm
Ssarx Subspace Identification Algorithm, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ssarx subspace identification algorithm/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
ssarx subspace identification algorithm - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ssarx  (MathWorks Inc)
90
MathWorks Inc ssarx
Ssarx, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ssarx/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
ssarx - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ssar  (Boehringer Ingelheim)
90
Boehringer Ingelheim ssar
Ssar, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ssar/product/Boehringer Ingelheim
Average 90 stars, based on 1 article reviews
ssar - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
search-and-subtract  (SAS institute)
90
SAS institute search-and-subtract
Search And Subtract, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/search-and-subtract/product/SAS institute
Average 90 stars, based on 1 article reviews
search-and-subtract - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sae/ssar report form  (Apexigen Inc)
90
Apexigen Inc sae/ssar report form
Sae/Ssar Report Form, supplied by Apexigen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sae/ssar report form/product/Apexigen Inc
Average 90 stars, based on 1 article reviews
sae/ssar report form - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
anti-ssar  (Novus Biologicals)
90
Novus Biologicals anti-ssar
Loss of stem and tumorigenic properties by GBM stem-like cells is accompanied <t>with</t> <t>GABA</t> metabolism deregulation characterized by enhanced GHB levels. a Increased GABA by-products to α-KG ratios in TG1-miR compared to TG1. The “+” sign represents the mean value in the whisker box . Mean ± SD, n = 6 independent biological samples. b Schematic reconstruction of metabolic pathways with green and red boxes signaling metabolites decreased or increased in TG1-miR compared to TG1, respectively. Enzyme names are within grey boxes . When relevant, the corresponding gene designation is indicated below the enzyme name. SSADH: succinic semialdehyde dehydrogenase. <t>SSAR</t> succinic semialdehyde reductase. c Downregulation of the ALDH5A1 protein product SSADH in TG1-miR. Western blot analysis. SSADH MW, 57 kDa; Actin MW, 42 kDa. Mean ± SD, n = 3 independent biological samples. d Decreased ALDH5A1 mRNA levels in TG1-miR compared to TG1. Q-PCR assays. Mean ± SD, n = 3 independent biological samples. e Targeting of the ALDH5A1 transcript by miR-302. Expression of Renilla Luciferase mRNA containing the wild-type form of ALDH5A1 -3′UTR is strongly reduced in TG1-miR compared to TG1. Deletion of miR-302 putative target sequence in the 3′UTR of ALDH5A1 mRNA ( ALDH5A1 -3′UTR-DEL) prevents the binding of the miR, and rescues luciferase activity. n = 3 independent biological samples. f Decreased SSADH levels in GBM and DIPG stem-like cells (TG1, TP54) upon ALDH5A1 downregulation with siRNAs (siA). siC (control siRNA). Mean ± SD, n = 3 independent biological samples. RDU, relative densitometry units. g ALDH5A1 down regulation results in enhanced GHB intra-cellular levels. Mean ± SD, n = 3 independent biological samples. h SSADH immunoreactive cells are enriched in proliferative/non-differentiated GBM territories ( P HIGH / D − ) and rare in non-proliferative/differentiated ( P LOW / D + ) tumor territories of patients’ GBM, as revealed by immunohistochemical staining of Ki67, Olig2, and GFAP. HES: hematoxylin and eosin staining. Scale bar 100 µm. i GHB/α-KG ratios in proliferative/non-differentiated ( P HIGH / D − ) and weakly proliferative/differentiated territories ( P LOW / D + ) of patient GBM. GC–MS/MS analysis. Mean ± SD, n = 5 independent patient’s GBM neurosurgical samples
Anti Ssar, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-ssar/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
anti-ssar - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
susar  (AstraZeneca ltd)
90
AstraZeneca ltd susar
Loss of stem and tumorigenic properties by GBM stem-like cells is accompanied <t>with</t> <t>GABA</t> metabolism deregulation characterized by enhanced GHB levels. a Increased GABA by-products to α-KG ratios in TG1-miR compared to TG1. The “+” sign represents the mean value in the whisker box . Mean ± SD, n = 6 independent biological samples. b Schematic reconstruction of metabolic pathways with green and red boxes signaling metabolites decreased or increased in TG1-miR compared to TG1, respectively. Enzyme names are within grey boxes . When relevant, the corresponding gene designation is indicated below the enzyme name. SSADH: succinic semialdehyde dehydrogenase. <t>SSAR</t> succinic semialdehyde reductase. c Downregulation of the ALDH5A1 protein product SSADH in TG1-miR. Western blot analysis. SSADH MW, 57 kDa; Actin MW, 42 kDa. Mean ± SD, n = 3 independent biological samples. d Decreased ALDH5A1 mRNA levels in TG1-miR compared to TG1. Q-PCR assays. Mean ± SD, n = 3 independent biological samples. e Targeting of the ALDH5A1 transcript by miR-302. Expression of Renilla Luciferase mRNA containing the wild-type form of ALDH5A1 -3′UTR is strongly reduced in TG1-miR compared to TG1. Deletion of miR-302 putative target sequence in the 3′UTR of ALDH5A1 mRNA ( ALDH5A1 -3′UTR-DEL) prevents the binding of the miR, and rescues luciferase activity. n = 3 independent biological samples. f Decreased SSADH levels in GBM and DIPG stem-like cells (TG1, TP54) upon ALDH5A1 downregulation with siRNAs (siA). siC (control siRNA). Mean ± SD, n = 3 independent biological samples. RDU, relative densitometry units. g ALDH5A1 down regulation results in enhanced GHB intra-cellular levels. Mean ± SD, n = 3 independent biological samples. h SSADH immunoreactive cells are enriched in proliferative/non-differentiated GBM territories ( P HIGH / D − ) and rare in non-proliferative/differentiated ( P LOW / D + ) tumor territories of patients’ GBM, as revealed by immunohistochemical staining of Ki67, Olig2, and GFAP. HES: hematoxylin and eosin staining. Scale bar 100 µm. i GHB/α-KG ratios in proliferative/non-differentiated ( P HIGH / D − ) and weakly proliferative/differentiated territories ( P LOW / D + ) of patient GBM. GC–MS/MS analysis. Mean ± SD, n = 5 independent patient’s GBM neurosurgical samples
Susar, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/susar/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
susar - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
metal gearmotors integrated 48 counts per revolution quadrature encoder  (Pololu Corporation)
90
Pololu Corporation metal gearmotors integrated 48 counts per revolution quadrature encoder
Loss of stem and tumorigenic properties by GBM stem-like cells is accompanied <t>with</t> <t>GABA</t> metabolism deregulation characterized by enhanced GHB levels. a Increased GABA by-products to α-KG ratios in TG1-miR compared to TG1. The “+” sign represents the mean value in the whisker box . Mean ± SD, n = 6 independent biological samples. b Schematic reconstruction of metabolic pathways with green and red boxes signaling metabolites decreased or increased in TG1-miR compared to TG1, respectively. Enzyme names are within grey boxes . When relevant, the corresponding gene designation is indicated below the enzyme name. SSADH: succinic semialdehyde dehydrogenase. <t>SSAR</t> succinic semialdehyde reductase. c Downregulation of the ALDH5A1 protein product SSADH in TG1-miR. Western blot analysis. SSADH MW, 57 kDa; Actin MW, 42 kDa. Mean ± SD, n = 3 independent biological samples. d Decreased ALDH5A1 mRNA levels in TG1-miR compared to TG1. Q-PCR assays. Mean ± SD, n = 3 independent biological samples. e Targeting of the ALDH5A1 transcript by miR-302. Expression of Renilla Luciferase mRNA containing the wild-type form of ALDH5A1 -3′UTR is strongly reduced in TG1-miR compared to TG1. Deletion of miR-302 putative target sequence in the 3′UTR of ALDH5A1 mRNA ( ALDH5A1 -3′UTR-DEL) prevents the binding of the miR, and rescues luciferase activity. n = 3 independent biological samples. f Decreased SSADH levels in GBM and DIPG stem-like cells (TG1, TP54) upon ALDH5A1 downregulation with siRNAs (siA). siC (control siRNA). Mean ± SD, n = 3 independent biological samples. RDU, relative densitometry units. g ALDH5A1 down regulation results in enhanced GHB intra-cellular levels. Mean ± SD, n = 3 independent biological samples. h SSADH immunoreactive cells are enriched in proliferative/non-differentiated GBM territories ( P HIGH / D − ) and rare in non-proliferative/differentiated ( P LOW / D + ) tumor territories of patients’ GBM, as revealed by immunohistochemical staining of Ki67, Olig2, and GFAP. HES: hematoxylin and eosin staining. Scale bar 100 µm. i GHB/α-KG ratios in proliferative/non-differentiated ( P HIGH / D − ) and weakly proliferative/differentiated territories ( P LOW / D + ) of patient GBM. GC–MS/MS analysis. Mean ± SD, n = 5 independent patient’s GBM neurosurgical samples
Metal Gearmotors Integrated 48 Counts Per Revolution Quadrature Encoder, supplied by Pololu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/metal gearmotors integrated 48 counts per revolution quadrature encoder/product/Pololu Corporation
Average 90 stars, based on 1 article reviews
metal gearmotors integrated 48 counts per revolution quadrature encoder - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Loss of stem and tumorigenic properties by GBM stem-like cells is accompanied with GABA metabolism deregulation characterized by enhanced GHB levels. a Increased GABA by-products to α-KG ratios in TG1-miR compared to TG1. The “+” sign represents the mean value in the whisker box . Mean ± SD, n = 6 independent biological samples. b Schematic reconstruction of metabolic pathways with green and red boxes signaling metabolites decreased or increased in TG1-miR compared to TG1, respectively. Enzyme names are within grey boxes . When relevant, the corresponding gene designation is indicated below the enzyme name. SSADH: succinic semialdehyde dehydrogenase. SSAR succinic semialdehyde reductase. c Downregulation of the ALDH5A1 protein product SSADH in TG1-miR. Western blot analysis. SSADH MW, 57 kDa; Actin MW, 42 kDa. Mean ± SD, n = 3 independent biological samples. d Decreased ALDH5A1 mRNA levels in TG1-miR compared to TG1. Q-PCR assays. Mean ± SD, n = 3 independent biological samples. e Targeting of the ALDH5A1 transcript by miR-302. Expression of Renilla Luciferase mRNA containing the wild-type form of ALDH5A1 -3′UTR is strongly reduced in TG1-miR compared to TG1. Deletion of miR-302 putative target sequence in the 3′UTR of ALDH5A1 mRNA ( ALDH5A1 -3′UTR-DEL) prevents the binding of the miR, and rescues luciferase activity. n = 3 independent biological samples. f Decreased SSADH levels in GBM and DIPG stem-like cells (TG1, TP54) upon ALDH5A1 downregulation with siRNAs (siA). siC (control siRNA). Mean ± SD, n = 3 independent biological samples. RDU, relative densitometry units. g ALDH5A1 down regulation results in enhanced GHB intra-cellular levels. Mean ± SD, n = 3 independent biological samples. h SSADH immunoreactive cells are enriched in proliferative/non-differentiated GBM territories ( P HIGH / D − ) and rare in non-proliferative/differentiated ( P LOW / D + ) tumor territories of patients’ GBM, as revealed by immunohistochemical staining of Ki67, Olig2, and GFAP. HES: hematoxylin and eosin staining. Scale bar 100 µm. i GHB/α-KG ratios in proliferative/non-differentiated ( P HIGH / D − ) and weakly proliferative/differentiated territories ( P LOW / D + ) of patient GBM. GC–MS/MS analysis. Mean ± SD, n = 5 independent patient’s GBM neurosurgical samples

Journal: Acta Neuropathologica

Article Title: A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma

doi: 10.1007/s00401-016-1659-5

Figure Lengend Snippet: Loss of stem and tumorigenic properties by GBM stem-like cells is accompanied with GABA metabolism deregulation characterized by enhanced GHB levels. a Increased GABA by-products to α-KG ratios in TG1-miR compared to TG1. The “+” sign represents the mean value in the whisker box . Mean ± SD, n = 6 independent biological samples. b Schematic reconstruction of metabolic pathways with green and red boxes signaling metabolites decreased or increased in TG1-miR compared to TG1, respectively. Enzyme names are within grey boxes . When relevant, the corresponding gene designation is indicated below the enzyme name. SSADH: succinic semialdehyde dehydrogenase. SSAR succinic semialdehyde reductase. c Downregulation of the ALDH5A1 protein product SSADH in TG1-miR. Western blot analysis. SSADH MW, 57 kDa; Actin MW, 42 kDa. Mean ± SD, n = 3 independent biological samples. d Decreased ALDH5A1 mRNA levels in TG1-miR compared to TG1. Q-PCR assays. Mean ± SD, n = 3 independent biological samples. e Targeting of the ALDH5A1 transcript by miR-302. Expression of Renilla Luciferase mRNA containing the wild-type form of ALDH5A1 -3′UTR is strongly reduced in TG1-miR compared to TG1. Deletion of miR-302 putative target sequence in the 3′UTR of ALDH5A1 mRNA ( ALDH5A1 -3′UTR-DEL) prevents the binding of the miR, and rescues luciferase activity. n = 3 independent biological samples. f Decreased SSADH levels in GBM and DIPG stem-like cells (TG1, TP54) upon ALDH5A1 downregulation with siRNAs (siA). siC (control siRNA). Mean ± SD, n = 3 independent biological samples. RDU, relative densitometry units. g ALDH5A1 down regulation results in enhanced GHB intra-cellular levels. Mean ± SD, n = 3 independent biological samples. h SSADH immunoreactive cells are enriched in proliferative/non-differentiated GBM territories ( P HIGH / D − ) and rare in non-proliferative/differentiated ( P LOW / D + ) tumor territories of patients’ GBM, as revealed by immunohistochemical staining of Ki67, Olig2, and GFAP. HES: hematoxylin and eosin staining. Scale bar 100 µm. i GHB/α-KG ratios in proliferative/non-differentiated ( P HIGH / D − ) and weakly proliferative/differentiated territories ( P LOW / D + ) of patient GBM. GC–MS/MS analysis. Mean ± SD, n = 5 independent patient’s GBM neurosurgical samples

Article Snippet: The following antibodies were used for immunoblotting: anti-Nanog (Cell Signaling, 1:1000), anti-p21 (Santa Cruz Biotechnology, 1:200), anti-Actin (Millipore Chemicon, 1:10,000), anti-SSAR (Novus biological, 1:2000), anti-ABAT1 (GABA-T) (Sigma Aldrich, 1:2500), anti-GAD65 (Abcam, 1:500), anti-GAD67 (Abcam, 1:500), anti-HOT (Sigma, 1:2000), anti-GLUD1 (Sigma, 1:2000), and anti-SSADH (Novus Biological, 1:2000).

Techniques: Whisker Assay, Western Blot, Expressing, Luciferase, Sequencing, Binding Assay, Activity Assay, Immunohistochemical staining, Staining, Gas Chromatography-Mass Spectrometry